Print this page

Understanding Batten
- CLN5
Current Research
Patient Stories
Resources
Diagnosis and Testing
- CLN5

Incidence

The rate of new (or newly diagnosed) cases of a disease.

Post navigation

Previous PostPrevious Glycoprotein

Next PostNext Joint laxity

LivingBatten is sponsored by Neurogene Inc., which is focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.

Learn More About Neurogene Inc.

Contact Us

866-574-4568 (US+1)

patientinfo@neurogene.com

Follow Us

Quick Links

Glossary of Terms
Terms of Use
Privacy Notice

Translation Disclaimer

This site is intended solely for US residents and is governed by US laws and regulations. Nothing on LivingBatten should be construed as medical advice, medical visits or recommendations from a healthcare provider. The information provided is for informational purposes only, and should not be used to replace a discussion with a healthcare professional. All decisions regarding patient care must be handled by a healthcare professional, and made based on the unique needs of each patient. While Neurogene makes reasonable efforts to include accurate, up-to-date information on this site, Neurogene makes no representations or warranties as to its accuracy. Neurogene assumes no liability for any errors or omissions in the content of this site.
© 2023 Neurogene Inc. All rights reserved. US-BAT-WEB-0001v14

Stay Connected

Home
Understanding Batten
- CLN5
- CLN7
Current Research
Batten Disease Patient Stories
Resources
Diagnosis and Testing
- CLN5 subtype of Batten Disease
- CLN7 subtype of Batten Disease
Facebook
Twitter
LinkedIn

1-877-237-5020